Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Behr

Agnes Behr, Budapest HU

Patent application numberDescriptionPublished
20110144104PYRROLIDINYL-ALKYL-AMIDE DERIVATIVES, THEIR PREPARATION, AND THEIR THERAPEUTIC APPLICATION AS CCR3 RECEPTOR LIGANDS - The present invention relates to pyrrolidinyl-alkyl-amide derivatives of formula (I) or (IA)06-16-2011

Bernard Behr, Saint Jean Saverne FR

Patent application numberDescriptionPublished
20110126373WIPER BLADE WITH A SUPPORTING ELEMENT - The invention is based on a wiper blade (06-02-2011

Bernd Leopold Behr, Hoechst AT

Patent application numberDescriptionPublished
20090242424METHOD AND APPARATUS FOR TREATING WATER OR WASTEWATER OR THE LIKE - A method and apparatus for treating water or wastewater for drinking and/or industrial use. The method and apparatus comprises of a plurality of vertically positioned electrodes, which are placed in a treating chamber and wherein the electrodes are interconnected to one another. The positive and negative electrodes are insulated there-between. The polarity of the direct current supply is changeable at regular intervals in order to prevent passivation of the electrodes when reaching an even abrasion. The current can preferably be pulsatory. In order to be able to keep the current density between the electrodes at a desired value, the most efficient possible electrolysis is achieved by means of a minimum total current and wherein the spacing between the electrodes are adjustable.10-01-2009

David Henry Behr, Ancaster CA

Patent application numberDescriptionPublished
20090266746MINERAL ORE FLOTATION AID - A method is provided for enhancing selective separation of ore values by addition of an effective amount of a treatment reagent to the separation process, such as froth flotation. The treatment reagent can be added at different stages, such as to a grinding mill, conditioning tank before flotation, or in the flotation cells before, after or simultaneous to the addition of other conventional flotation reagents. By adding the treatment agent, the recovery of valuable minerals from a froth flotation process is increased. In an embodiment of the present invention, the treatment reagent is a water-soluble ethylene oxide/propylene oxide copolymer.10-29-2009

France Jean-Paul Behr, Strasbourg FR

Patent application numberDescriptionPublished
20110118331CATIONIC SIRNAS, SYNTHESIS AND USE FOR RNA INTERFERENCE - The invention relates to cationic siRNAs, characterized in that they are double-stranded RNA fragments, grafted to the ends of which are oligocations, the number of cationic charges grafted being comparable to or greater than that of the anionic charges carried by the internucleoside phosphates of the RNA strands.05-19-2011

Jean-Paul Behr, Strasbourg FR

Patent application numberDescriptionPublished
20090069262Cationic Oligonucleotides, Automated Methods for Preparing Same and Their Uses - The invention relates to oligonucleotide-oligocation molecules A03-12-2009
20100048672COMPOSITIONS FOR TRANSFECTION OF OLIGONUCLEOTIDES ACTIVE FOR GENE SILENCING AND THEIR BIOLOGICAL AND THERAPEUTICAL APPLICATIONS - The invention relates to compositions of transfection comprising an oligonucleotide and an amphiphilic cationic molecule of formula (I) wherein, —X is N—R02-25-2010

Patent applications by Jean-Paul Behr, Strasbourg FR

Marcel Behr, Montreal CA

Patent application numberDescriptionPublished
20080254052MOLECULAR DIFFERENCES BETWEEN SPECIES OF THE M. TUBERCULOSIS COMPLEX - Specific genetic deletion are identified in mycobacteria isolates, including variations in the 10-16-2008
20110206715MOLECULAR DIFFERENCES BETWEEN SPECIES OF THE M. TUBERCULOSIS COMPLEX - Specific genetic deletion are identified in mycobacteria isolates, including variations in the 08-25-2011

Patent applications by Marcel Behr, Montreal CA

Pascal Behr, Zurich CH

Patent application numberDescriptionPublished
20110124027PROBE ARRANGEMENT FOR EXCHANGING IN A CONTROLLABLE WAY LIQUIDS WITH MICRO-SIZED SAMPLES OF MATERIAL LIKE BIOLOGICAL CELLS - The invention relates to a probe arrangement (05-26-2011

Stephen Behr, Outremont CA

Patent application numberDescriptionPublished
20110311661Plant Extracts and Dermatological Uses Thereof - Plant extracts and dermatological formulations comprising one or more plant extracts that are capable of inhibiting one or more extracellular proteases selected from the group of: matrix metalloprotease-1 (MMP-1), matrix metalloprotease-2 (MMP-2), matrix metalloprotease-3 (MMP-3), matrix metalloprotease-9 (MMP-9) and human leukocyte elastase (HLE). A rapid method for screening plant extracts to identify those having the above activity that are suitable for incorporation into the dermatological formulations of the invention. The use of the plant extracts as dermatological agents suitable for the treatment or prevention of various dermatological conditions, including wrinkling or sagging of the skin, irradiation induced skin and/or hair damage, deepening of skin lines, elastotic changes in the skin, as well as for the routine care of the skin, hair and/or nails.12-22-2011

Thomas Behr, Zurich CH